Hcsg.O
Healthcare Services Group operates in the multiline insurance and brokerage sector, generating revenue through insurance services and related commercial activities.
Business. Healthcare Services Group operates in the multiline insurance and brokerage sector, generating revenue through insurance services and related commercial activities.
Analyst recommendations
6 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Healthcare Services Group operates in the multiline insurance and brokerage sector, generating revenue through insurance services and related commercial activities.
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no recorded interest-bearing debt on the balance sheet. Liquidity is supported by cash and equivalents of $125.2 million against total assets of $794.3 million, resulting in a low liquidity risk assessment. The firm generates robust operating cash flow of $145.0 million, which significantly exceeds its capital expenditure of $5.8 million, providing ample free cash flow for operations or potential return of capital.
Profitability metrics demonstrate strong returns, with a return on equity of 24.1% and a return on assets of 15.5%. The net income of $59.1 million on revenue of $1.84 billion yields a net margin of approximately 3.2%. While specific cohort median comparisons are absent from the input data, the high ROE and ROA suggest efficient capital utilization relative to typical insurance industry benchmarks. The valuation snapshot shows a price-to-earnings ratio of 13.44 and a price-to-book ratio of 3.24, reflecting a premium valuation relative to book value but a moderate multiple on earnings.
- The company operates with zero debt, resulting in a debt-to-equity ratio of 0.0 and eliminating interest rate risk.
- Strong profitability is evidenced by a 24.1% return on equity and 15.5% return on assets.
- Operating cash flow of $145.0 million significantly exceeds capital expenditures of $5.8 million, generating substantial free cash flow.
- Analyst consensus suggests upside potential, with a mean price target of $26.80 versus the current price of $23.75.
- Dilution risk is assessed as low, with no difference between basic and diluted shares outstanding.
Bull / Bear case
analysis pipelineIn focus — financials by report
Revenue $470.8M, +2,7% YoY; Operating income +148,1% YoY.
- ▍Revenue $470.8M, +2,7% YoY
- ▍Operating income +148,1% YoY
- ▍Net income +170,1% YoY
- ▍Free cash flow +185,6% YoY
- ▍Net margin 4.8%
Revenue $462.8M, +3,4% YoY; Operating income +47,1% YoY.
- ▍Revenue $462.8M, +3,4% YoY
- ▍Operating income +47,1% YoY
- ▍Net income +51,3% YoY
- ▍Free cash flow +46,9% YoY
- ▍Net margin 5.6%
Revenue $466.7M, +6,6% YoY; Operating income +87,8% YoY.
- ▍Revenue $466.7M, +6,6% YoY
- ▍Operating income +87,8% YoY
- ▍Net income +162,1% YoY
- ▍Free cash flow +139,3% YoY
- ▍Net margin 6.7%
Revenue $464.3M, +8,4% YoY; Operating income +177,4% YoY.
- ▍Revenue $464.3M, +8,4% YoY
- ▍Operating income +177,4% YoY
- ▍Net income +206,2% YoY
- ▍Free cash flow +178,2% YoY
- ▍Net margin 9.3%
Revenue $458.5M; Operating income -$46.2M.
- ▍Revenue $458.5M
- ▍Operating income -$46.2M
- ▍Net margin -7.1%
Revenue $447.7M; Operating income $23.0M.
- ▍Revenue $447.7M
- ▍Operating income $23.0M
- ▍Net margin 3.8%
Revenue $437.8M; Operating income $13.8M.
- ▍Revenue $437.8M
- ▍Operating income $13.8M
- ▍Net margin 2.7%
Revenue $428.1M; Operating income $16.5M.
- ▍Revenue $428.1M
- ▍Operating income $16.5M
- ▍Net margin 3.3%
Revenue $1.84B, +7,1% YoY; Operating income +7,8% YoY.
- ▍Revenue $1.84B, +7,1% YoY
- ▍Operating income +7,8% YoY
- ▍Net income +49,6% YoY
- ▍Free cash flow +46,7% YoY
- ▍Net margin 3.2%
Revenue $1.72B, +2,6% YoY; Operating income −6,1% YoY.
- ▍Revenue $1.72B, +2,6% YoY
- ▍Operating income −6,1% YoY
- ▍Net income +2,8% YoY
- ▍Free cash flow +16,6% YoY
- ▍Net margin 2.3%
Revenue $1.67B, −1,1% YoY; Operating income −9,4% YoY.
- ▍Revenue $1.67B, −1,1% YoY
- ▍Operating income −9,4% YoY
- ▍Net income +12,1% YoY
- ▍Free cash flow +315,1% YoY
- ▍Net margin 2.3%
Revenue $1.69B, +2,9% YoY; Operating income −7,8% YoY.
- ▍Revenue $1.69B, +2,9% YoY
- ▍Operating income −7,8% YoY
- ▍Net income −29,5% YoY
- ▍Free cash flow −304,5% YoY
- ▍Net margin 2.0%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 1,13 |
| Revenue | —no estimate | —no estimate | 1,9B USD |
| Operating income | —no estimate | —no estimate | 104,6M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- EVP & Chief Financial Officer · Restricted Stock Units → Common StockDisposed 935exercise · 2026-05-27
- EVP & Chief Financial Officer · Restricted Stock Units → Common StockAcquired 2 202grant · 2026-05-27
- EVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 4 416exercise · 2026-02-24
- EVP/Gen. Counsel/Corp. Secty. · Restricted Stock Units → Common StockDisposed 3 374exercise · 2026-02-24
- Director, President & CEO · Restricted Stock Units → Common StockDisposed 22 238exercise · 2026-02-24
- EVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 416exercise · 2026-02-24
- EVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 3 340exercise · 2026-02-24
- EVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 21 075 @ $18,10exercise · 2026-02-18
- EVP & Chief Admin. Officer · Stock Option (right to buy) → Common StockDisposed 29 579 @ $18,10exercise · 2026-02-18
- EVP & Chief Admin. Officer · Stock Option (right to buy) → Common StockDisposed 9 278 @ $13,72exercise · 2026-02-18
- EVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 12 216 @ $10,36exercise · 2026-02-18
- EVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 7 016 @ $13,72exercise · 2026-02-18
- EVP & Chief Revenue Officer · Stock Option (right to buy) → Common StockDisposed 5 193 @ $11,76exercise · 2026-02-18
- EVP & Chief Admin. Officer · Restricted Stock Units → Common StockAcquired 18 832grant · 2026-01-05
- EVP & Chief Revenue Officer · Restricted Stock Units → Common StockAcquired 18 852grant · 2026-01-05
- EVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 2 002exercise · 2026-01-04
- EVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 3 317exercise · 2026-01-04
- EVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 2 363exercise · 2026-01-04
- EVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 1 498exercise · 2026-01-04
- EVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 6 345exercise · 2026-01-03
- EVP & Chief Admin. Officer · Restricted Stock Units → Common StockDisposed 5 683exercise · 2026-01-03
- EVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 5 373exercise · 2026-01-03
- EVP & Chief Revenue Officer · Restricted Stock Units → Common StockDisposed 5 970exercise · 2026-01-03
- EVP & Chief Revenue Officer · Phantom Stock → Common StockAcquired 1 444grant · 2025-12-31
- EVP & Chief Admin. Officer · Phantom Stock → Common StockAcquired 1 393grant · 2025-12-31
Actions
Ask Handelsavisen
- Reference data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- HEALTHCARE SERVICES GROUP, INC. Market data — financials · 2026-07-29
- reconciler_enqueue (reconciler) on HCSG.O · 2026-07-29
- Healthcare Services Group Inc Market data — analyst estimates · 2026-07-29
- Healthcare Services Group Inc Market data — ESG · 2026-07-29
- HCSG.O HA canonical relationships · 2026-07-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,02 %$47M
- Investment Managers · as of 2026-03-310,01 %$26M
- Institutional Investor · as of 2026-03-310,01 %$40M
- Investment Managers · as of 2026-03-310,01 %$45M
- Investment Managers · as of 2026-03-310,01 %$20M
- Institutional Investor · as of 2026-03-310,01 %$17M
- Investment Managers · as of 2026-03-310,01 %$22M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$25M
- Investment Managers · as of 2024-06-300,00 %$135M
- Brokerage Firms · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$22M
- Investment Managers · as of 2024-12-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$38M
- Funds · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2025-12-310,00 %$154M
- Institutional Investor · as of 2026-03-310,00 %$36M
- Investment Managers · as of 2026-03-310,00 %$52M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$13M
- Institutional Investor · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$19M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Theodore WahlPresident, Chief Executive Officer, Director
Insider activity
- SVP & Chief Accounting Officer · Common StockOther 4 381 · 2026-07-01
- Director · Common StockOther 102 @ $24,56$3K · 2026-06-30
- Director · Common StockOther 306 @ $24,56$8K · 2026-06-30
- Director · Common StockOther 611 @ $24,56$15K · 2026-06-30
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 1 969 @ $20,32$40K · 2026-05-26
- Director · Common StockOther 809 @ $18,55$15K · 2026-03-31
- Director · Common StockOther 405 @ $18,55$8K · 2026-03-31
- Director · Common StockOther 135 @ $18,55$3K · 2026-03-31
- SVP & Chief Accounting Officer · Common StockSold 2 490 @ $21,75$54K · 2026-02-26
- EVP & Chief Operating Officer · Common StockOther 4 416 · 2026-02-24
- EVP & Chief Operating Officer · Common StockOther 1 874 @ $21,40$40K · 2026-02-24
- EVP & Chief Operating Officer · Common StockOther 12 618 · 2026-02-24
- EVP & Chief Operating Officer · Common StockOther 5 353 @ $21,40$115K · 2026-02-24
- EVP & Chief Revenue Officer · Common StockOther 3 340 · 2026-02-24
- EVP & Chief Revenue Officer · Common StockOther 1 417 @ $21,40$30K · 2026-02-24
- EVP & Chief Revenue Officer · Common StockOther 9 543 · 2026-02-24
- EVP & Chief Revenue Officer · Common StockOther 4 049 @ $21,40$87K · 2026-02-24
- Director, President & CEO · Common StockOther 22 238 · 2026-02-24
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Capex (annual): USD 5.82MUnknown
- Current assets (annual): USD 576.41MUnknown
- EPS (basic) (annual): USD-PER-SHARES 1Unknown
- Current liabilities (annual): USD 170.38MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 1Unknown
- Shareholders' equity (annual): USD 510.21MUnknown
- Total assets (annual): USD 794.25MUnknown
- Shares outstanding (annual): 69.6MUnknown
- Cash & equivalents (annual): USD 125.19MUnknown
- Cost of revenue (annual): USD 1.6BUnknown
- Revenue (annual): USD 1.84BUnknown
- Operating cash flow (annual): USD 144.97MUnknown
- Pre-tax income (annual): USD 67.87MUnknown
- Net income (annual): USD 59.06MUnknown
- Pre-tax income (annual): USD 52.94MUnknown
- Cash & equivalents (annual): USD 56.78MUnknown
- Net income (annual): USD 39.47MUnknown
- Cost of revenue (annual): USD 1.49BUnknown
- Capex (annual): USD 6.34MUnknown
- Total assets (annual): USD 802.77MUnknown
- Current assets (annual): USD 556.65MUnknown
- Shares outstanding (annual): 73.2MUnknown
- Operating cash flow (annual): USD 30.8MUnknown
- Revenue (annual): USD 1.72BUnknown